Difference between revisions of "Belumosudil (Rezurock)"
Jump to navigation
Jump to search
m |
m (→Also known as) |
||
| Line 9: | Line 9: | ||
==Also known as== | ==Also known as== | ||
| − | *'''Code names:''' | + | *'''Code names:''' KD-025, SLx-2119 |
*'''Brand name:''' Rezurock | *'''Brand name:''' Rezurock | ||
Latest revision as of 02:27, 11 August 2023
Mechanism of action
ROCK2 (Rho-associated coiled-coil kinase 2) inhibitor
Diseases for which it is used
History of changes in FDA indication
- 2021-07-16: Approved for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. (Based on ROCKstar)
Also known as
- Code names: KD-025, SLx-2119
- Brand name: Rezurock